Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PDK1 | Q15118 | 4/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.42 |
| ▸ | PDK3 | Q15120 | 4/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30450959 | 0.83 | CYP1A2 (0.46) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL997814 | 0.83 | CYP1A2 (0.46) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL583285 | 0.83 | CYP1A2 (0.46) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL9888570 | 0.83 | CYP1A2 (0.46) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL2398996 | 0.79 | MAPT (0.50) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL23838114 | 0.79 | MAPK1 (0.47) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL11205832 | 0.78 | PTPN1 (0.48) | RAB9AALDH1A1PTPN1TSHRMAPT | |
| SCHEMBL680607 | 0.78 | CES1 (0.57) | MAPK1NPC1RAB9AALDH1A1PTPN1 | |
| SCHEMBL20954606 | 0.75 | ALDH1A1 (0.39) | MAPK1NPC1RAB9AALDH1A1PDK1 | |
| SCHEMBL583794 | 0.75 | CYP1A2 (0.43) | MAPK1NPC1RAB9AALDH1A1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049052-A1 | Methods of Synthesizing Chromophore Acceptors | LIGHTWAVE LOGIC, INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-20260085190-A1 | Chromophores with New Acceptors that Increase Refractive Index | LIGHTWAVE LOGIC, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2026039610-A1 | METHODS OF SYNTHESIZING CHROMOPHORE ACCEPTORS | LIGHTWAVE LOGIC, INC. (US) | 2026-02-19 | — | — | WO | disclosed |
| US-20260049052-A1 | Methods of Synthesizing Chromophore Acceptors | LIGHTWAVE LOGIC, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260049052-A1 | Methods of Synthesizing Chromophore Acceptors | LIGHTWAVE LOGIC, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-8574468-B1 | Benzo-fused heterocyclic chromophores for nonlinear optical devices | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-11-05 | — | — | US | disclosed |
| US-8574467-B1 | Benzo-fused heterocyclic chromophores for nonlinear optical devices | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-11-05 | — | — | US | disclosed |
| EP-2595975-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX | Corning Incorporated (US) | 2013-05-29 | — | — | EP | disclosed |
| US-20120329865-A1 | MOLECULES RELATED hERG ION CHANNELS AND THE USE THEREOF | CORNING INCORPORATED | 2012-12-27 | — | — | US | disclosed |
| US-20120022116-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX | CORNING INCORPORATED | 2012-01-26 | — | — | US | disclosed |
| WO-2012012278-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX | CORNING INCORPORATED (US) | 2012-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022116-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX | GPR35, GPR65, GPR68 | MAPK1 2444/4885NPC1 496/4885RAB9A 2178/4885 |
| US-20260049052-A1 | Methods of Synthesizing Chromophore Acceptors | PF4, PAH, FGFR4 | MAPK1 1366/4885NPC1 1268/4885RAB9A 4279/4885 |
| US-20260085190-A1 | Chromophores with New Acceptors that Increase Refractive Index | SCO2, HCN1, LBR | MAPK1 1247/4885NPC1 909/4885RAB9A 1580/4885 |
| US-20120329865-A1 | MOLECULES RELATED hERG ION CHANNELS AND THE USE THEREOF | KCNH2, KCNJ2, KCNH3 | MAPK1 3183/4885NPC1 278/4885RAB9A 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.